Skip to main content
. 2018 Feb 13;24(7):1170–1176. doi: 10.1177/1076029618757344

Table 4.

Parameters of APTT Waveform in Patients With Hemophilia With or Without Inhibitor, Those With VWD, and Patients Treated With Warfarin.

Warfarin Hemophilia Hemophilia With Inhibitor VWD
Peak of acceleration 42.8 (38.0-49.4) 53.9a (44.1-66.5) 112b (69.0-120) 46.7 (32.5-59.5)
Height of acceleration-1 421 (162-499) 237 (161-354) 25.3b (20.9-33.5) 397 (360-510)
Height of acceleration-2 54.0 (46.7-73.2) 93.7 (57.2-167) 5.01b (3.90-5.80) 241c (176-257)
Width of acceleration-1 11.6 (9.10-20.1) 20.0a (15.7-28.0) 43.2a (23.1-88.7) 13.4 (10.4-22.1)
Width of acceleration-2 58.1 (48.2-86.8) 49.4 (35.0-195) 210 (40.0-283) 41.8 (35.6-300)
Peak of velocity 103 (75.4-150) 64.9a (52.2-85.0)) 154.3 (83.8-219) 52.4a (36.8-72.4)
Height of velocity 183 (117-216) 155 (113-217) 27.9c (24.7-50.7) 209 (182-485)
Width of velocity 72.2 (61.1-99.6) 64.0 (50.1-100) 234 (52.9-316) 52.0 (43.4-100)
Peak of ½ fibrin formation 51.9 (44.3-88.5) 66.2 (54.4-104) 159b (118-223) 53.8 (37.9-73.7)
Height of ½ fibrin formation 246 (188-317) 443b (296-578) 502a (252-870) 302 (182-336)

Abbreviations: APTT, activated partial thromboplastin time; VWD, von Willebrand disease; Warfarin, patients treated with warfarin.

a P < .05 compared with patients treated with warfarin.

b P < .01 compared with patients treated with warfarin.

c P < .001 compared with patients treated with warfarin.